Local view for "http://purl.org/linkedpolitics/eu/plenary/2017-04-04-Speech-2-437-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2017-04-04"^^xsd:date2
dcterms:Is Part Of	lp_eu:Medical devices - In vitro diagnostic medical devices (debate)2
dcterms:Language	"en"^^xsd:language2
lpv:document identification number	"en.20170404.22.2-437-000"2
lpv:hasSubsequent	lp_eu:2017-04-04-Speech-2-438-0002
lpv:speaker	lp:Dame Glenis Willmott2
lpv:spoken text	"Mr President, thank you all for your support and comments. The medical devices industry is hugely important in the EU, with over 25 000 companies employing almost 600 000 people. That is a lot of people. Throughout our work on this legislation, we had in mind that we needed stronger rules to improve device safety and protect patients without stifling the innovation that is a key feature of the industry in Europe. I believe the agreement that we have reached strikes the right balance. This will strengthen requirements for medical devices, and require high-risk devices to undergo additional pre-market assessment. Stricter rules on post-market surveillance will also ensure a faster response if there is a problem with a device and a new ID system will improve traceability. It is clear that Member States will have to cooperate and share information, and the new EU-wide database EUDAMED will help them do that. And importantly, patients will have more information on the devices they use or are treated with. Unfortunately, we cannot go back in time and prevent past scandals from happening, but with this legislation, we can make them much less likely in the future. Patients rightly expect that if a device has been placed on the market, then it must be safe. But unfortunately this has not always been the case. We have a responsibility to make sure that patients can have confidence in the medical devices industry and I firmly believe that this is what the agreement we will be voting for this week will do. Once again, thank you to everyone who has helped us to get to this stage, and again in particular to all of our staff and the Group staff, who have worked their socks off on this. I hope we have strong support in the vote tomorrow, because at the end of the day, this is about the safety of patients across the EU, and nothing can be more important than that."@en1
lpv:spokenAs	member; ENVI (2017-01-19--2017-10-02)3 substitute; EMPL (2017-01-19--2017-10-02)3 member; Delegation for relations with the United States (2017-02-13--2017-10-02)3 member; S&D (2014-07-01--2017-10-02)3 unknown; Labour Party (2014-07-01--2017-10-02)3 substitute; Delegation for relations with Switzerland and Norway and to the EU-Iceland Joint Parliamentary Committee and the European Economic Area (EEA) Joint Parliamentary Committee (2014-09-17--2017-10-02)3
lpv:unclassifiedMetadata	"Glenis Willmott,"1 "rapporteur"1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph